The weekly litigation news digest is live. Subscribe now

Samyang Biopharmaceuticals competitive analysis

Loading summary...

Explore Samyang Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof1

Latest PTAB cases involving Samyang Biopharmaceuticals

Discover the latest PTAB cases involving Samyang Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Samyang Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SAMYANG BIOPHARMACEUTICALS - 1 - -
HEXAL573 - -